Head-to-head · WeighScore
Lumora vs Shapely
The verdict
Lumora takes it — 66.1/100 to 65.4/100, but only just.
Lumora grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lumora (Blue Skies MD LLC dba Lumora MD) is a physician-founded telehealth platform offering compounded semaglutide and tirzepatide in injectable and sublingual forms. Shapely is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Lumora | Shapely |
|---|---|---|
| WeighScore | 66.1/100 | 65.4/100 |
| Grade | C | C |
| Scorecard rank | #206 | #225 |
| Semaglutide | $199/mo (starting dose, plus a separate fee, compounded) | Not disclosed |
| Tirzepatide | $299/mo (starting dose, compounded) | Not disclosed |
| Coverage | Coverage not published | 4 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Injection only |
Graded #206 · C
Strengths
- Compounded semaglutide (5 dose tiers) and tirzepatide (6 dose tiers) in injectable and sublingual forms
- Physician-founded by board-certified Drs. Sean and Shannon Arora (Arora Health & Aesthetics); clinician reviews every assessment
- LegitScript certified, HIPAA compliant, medications dispensed through licensed U.S. pharmacy partners
- Visit fees, medication, labs, and follow-up all included; full pricing shown before commitment
- Peptide therapies offered including NAD+, sermorelin, glutathione, gonadorelin, and PT-141
Where it loses points
- Pricing is fully gated behind the assessment — no public pricing; actual monthly costs unverifiable without completing intake
- Compounded medications are not FDA-approved; compounding pharmacy partners not publicly named
- Newer brand with 2026 founding; no Trustpilot rating or accessible public patient reviews found
- No dietitian, coaching, or HSA/FSA eligibility disclosed on public pages
- Claims all 50 states but 'treatment options may vary by state' with no explicit state-by-state coverage list
Graded #225 · C
Strengths
- Founded by Dr. Justin Zaghi, MD/MBA — Harvard-trained, board-certified in internal medicine and obesity medicine, with Medical Director Ana Lisa
- Brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro, Foundayo) covered by major PPO and Medicare at copay
- Compounded semaglutide from $99/month with free 2-day shipping, syringes, and supplies included via 503A/503B pharmacy
- 1:1 registered dietitian (RDN) and monthly video provider visits included in every plan; unlimited chat and app support
- Cellular smart scale provided to qualifying patients for ongoing weight tracking throughout the program
Where it loses points
- Currently available only in California, Florida, New York, and Texas — 46 states unserved despite announced expansion
- Telehealth subscription ($99/mo self-pay, $49 first-month promo) is charged separately from compounded medication cost
- Labs not included — $75 flat rate for uninsured patients; baseline bloodwork may be required before prescribing
- No LegitScript certification found on any public page
- Compounding pharmacy partner not named publicly; 503A/503B status claimed but specific pharmacy undisclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.